Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
TLX
Telix Pharmaceuticals Ltd
NASDAQ · Pharmaceutical Preparations
Last close
$10.97
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Pharmaceutical Preparations
RECENT INSIDER TRADES
2026-09-14
· Smith Darren Charlton
(Group Chief Financial Officer)
· BUY
2026-05-06
· Behrenbruch Christian
(MD & Group CEO)
· BUY
2026-04-01
· Smith Darren Charlton
(Group Chief Financial Officer)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
62
Shares held
3,180,104
Value
$36.18M
Percent of shares outstanding
0.94%
As of quarter end
2026-06-30
RECENT NEWS
Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
Telix Pharmaceuticals: Merger Bodes Well For Long-Term Plan
Why is Telix Pharmaceuticals stock rallying today?
Telix Pharmaceuticals Limited (TLX) Discusses Strategic Overview and Oncology Pipeline at Research and Development Day - Slideshow
Telix Pharmaceuticals Limited (TLX) M&A Call Transcript
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Telix Pharmaceuticals Ltd (TLX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit